EyePoint Pharmaceuticals Inc

+0.67 (+7.41%)
Earnings Announcements

Eyepoint Pharmaceuticals Reports Q1 Loss Per Share Of 56 Cents

Published: 05/04/2022 12:21 GMT
EyePoint Pharmaceuticals Inc (EYPT) - Eyepoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments.
Q1 Loss per Share $0.56.
Q1 Revenue $9.3 Million.
Q1 Earnings per Share View $-0.58, Revenue View $9.9 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $11.12 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $11.91 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.